Jaguar Health, Inc. Financial Ratios
JAGX|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-592.7%
Profit Margin
-329.3%
Net Income / Revenue
Asset Turnover
0.31
Revenue / Total Assets
Equity Multiplier
5.90
Total Assets / Equity
Composite: -592.7% (reported: -592.7%)
Profitability
Liquidity
Current Ratio
0.50
Quick Ratio
0.29
Solvency
Interest Coverage
-127.20
Efficiency
Asset Turnover
0.31
Inventory Turnover
0.01
Days Sales Outstanding
47 days
As of FY2025 · SEC 10-K · Updated Jun 24, 2026
Earnings Quality
Accrual Ratio
-19.9%
-4.8pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.